Biobetter Biologics
- 1 January 2015
- book chapter
- Published by Elsevier BV
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- Antibodies to watch in 2013mAbs, 2013
- Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass SpectrometryAnalytical Chemistry, 2012
- An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximabMolecular Immunology, 2012
- Introduction to current and future protein therapeutics: A protein engineering perspectiveExperimental Cell Research, 2011
- Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritisBritish Journal of Pharmacology, 2011
- Biosimilar, biobetter and next generation therapeutic antibodiesmAbs, 2011
- Strategies and challenges for the next generation of therapeutic antibodiesNature Reviews Immunology, 2010
- Therapeutic antibodies for autoimmunity and inflammationNature Reviews Immunology, 2010
- Gearing up for follow-on biologicsNature Reviews Drug Discovery, 2009
- Potent antibody therapeutics by designNature Reviews Immunology, 2006